UnitedHealth Group (UNH) - Credit Memo 2026

Sell
Rating
$397
Target Price
26%
Upside

Executive Summary

UnitedHealth Group continues to demonstrate strong market resilience. Our proprietary Credit Memo model indicates robust fundamentals despite macroeconomic headwinds. Key catalysts include product innovation in AI and strategic cost optimization.

Valuation Methodology

We utilize a blended approach of DCF (50%) and EV/EBITDA multiples (50%). Our WACC assumption is 9.1% based on a beta of 1.17.

Risk Factors

Generated by Office Nexus Analytical Engine | 2026-02-19